US2012329078A1PendingUtilityA1
Method of diagnosing cancer using g-csf protein having a deletion of an amino acid sequence corresponding to exon 3 as a diagnostic cancer marker
Est. expirySep 28, 2021(expired)· nominal 20-yr term from priority
C12Q 2600/156C12N 15/11C12Q 1/6886C07K 16/243
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
Claims
exact text as granted — not AI-modified1 .- 13 . (canceled)
14 . A method of diagnosing cancer comprising the steps of: (a) obtaining a G-CSF protein sample from mammalian tissues or cells; and (b) detecting a deletion of an amino acid sequence corresponding to exon 3 of a G-CSF gene in said G-CSF protein sample.Join the waitlist — get patent alerts
Track US2012329078A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.